» Articles » PMID: 33392129

Air Pollution and Central Nervous System Disease: A Review of the Impact of Fine Particulate Matter on Neurological Disorders

Overview
Specialty Public Health
Date 2021 Jan 4
PMID 33392129
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

It is widely known that the harmful effects of fine dust can cause various diseases. Research on the correlation between fine dust and health has been mainly focused on lung and cardiovascular diseases. By contrast, the effects of air pollution on the central nervous system (CNS) are not broadly recognized. Air pollution can cause diverse neurological disorders as the result of inflammation of the nervous system, oxidative stress, activation of microglial cells, protein condensation, and cerebral vascular-barrier disorders, but uncertainty remains concerning the biological mechanisms by which air pollution produces neurological disease. Neuronal cell damage caused by fine dust, especially in fetuses and infants, can cause permanent brain damage or lead to neurological disease in adulthood. It is necessary to study the air pollution-CNS disease connection with particular care and commitment. Moreover, the epidemiological and experimental study of the association between exposure to air pollution and CNS damage is critical to public health and quality of life. Here, we summarize the correlations between fine dust exposure and neurological disorders reported so far and make suggestions on the direction future research should take.

Citing Articles

Therapeutic Potential of Herbal Medicines in Combating Particulate Matter (PM)-Induced Health Effects: Insights from Recent Studies.

Intharuksa A, Arunotayanun W, Takuathung M, Boongla Y, Chaichit S, Khamnuan S Antioxidants (Basel). 2025; 14(1).

PMID: 39857357 PMC: 11762796. DOI: 10.3390/antiox14010023.


Considering the interconnected nature of social identities in neuroimaging research.

Dhamala E, Ricard J, Uddin L, Galea L, Jacobs E, Yip S Nat Neurosci. 2024; 28(2):222-233.

PMID: 39730766 DOI: 10.1038/s41593-024-01832-y.


Association Between Exposure to Particulate Matter and the Incidence of Parkinson's Disease: A Nationwide Cohort Study in Taiwan.

Chen T, Liang C, Chang C, Yang C, Yu H, Wu Y J Mov Disord. 2024; 17(3):313-321.

PMID: 38887056 PMC: 11300401. DOI: 10.14802/jmd.24003.


Exercise-Mediated Protection against Air Pollution-Induced Immune Damage: Mechanisms, Challenges, and Future Directions.

Jin X, Chen Y, Xu B, Tian H Biology (Basel). 2024; 13(4).

PMID: 38666859 PMC: 11047937. DOI: 10.3390/biology13040247.


Air pollution and neurological diseases, current state highlights.

Roy R, DAngiulli A Front Neurosci. 2024; 18:1351721.

PMID: 38510465 PMC: 10950980. DOI: 10.3389/fnins.2024.1351721.


References
1.
Luyten L, Saenen N, Janssen B, Vrijens K, Plusquin M, Roels H . Air pollution and the fetal origin of disease: A systematic review of the molecular signatures of air pollution exposure in human placenta. Environ Res. 2018; 166:310-323. DOI: 10.1016/j.envres.2018.03.025. View

2.
Calderon-Garciduenas L, Solt A, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L . Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children.... Toxicol Pathol. 2008; 36(2):289-310. DOI: 10.1177/0192623307313011. View

3.
Zeng Y, Lin R, Liu L, Liu Y, Li Y . Ambient air pollution exposure and risk of depression: A systematic review and meta-analysis of observational studies. Psychiatry Res. 2019; 276:69-78. DOI: 10.1016/j.psychres.2019.04.019. View

4.
Nabizadeh R, Yousefian F, Kazemi Moghadam V, Hadei M . Characteristics of cohort studies of long-term exposure to PM: a systematic review. Environ Sci Pollut Res Int. 2019; 26(30):30755-30771. DOI: 10.1007/s11356-019-06382-6. View

5.
Chen L, Yokel R, Hennig B, Toborek M . Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol. 2008; 3(4):286-95. PMC: 2771674. DOI: 10.1007/s11481-008-9131-5. View